Cargando…

Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics

Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukunishi, Yoshifumi, Mashimo, Tadaaki, Misoo, Kiyotaka, Wakabayashi, Yoshinori, Miyaki, Toshiaki, Ohta, Seiji, Nakamura, Mayu, Ikeda, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080912/
https://www.ncbi.nlm.nih.gov/pubmed/27075578
http://dx.doi.org/10.2174/1381612822666160414142547
_version_ 1782462822145327104
author Fukunishi, Yoshifumi
Mashimo, Tadaaki
Misoo, Kiyotaka
Wakabayashi, Yoshinori
Miyaki, Toshiaki
Ohta, Seiji
Nakamura, Mayu
Ikeda, Kazuyoshi
author_facet Fukunishi, Yoshifumi
Mashimo, Tadaaki
Misoo, Kiyotaka
Wakabayashi, Yoshinori
Miyaki, Toshiaki
Ohta, Seiji
Nakamura, Mayu
Ikeda, Kazuyoshi
author_sort Fukunishi, Yoshifumi
collection PubMed
description Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design.
format Online
Article
Text
id pubmed-5080912
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-50809122016-11-14 Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics Fukunishi, Yoshifumi Mashimo, Tadaaki Misoo, Kiyotaka Wakabayashi, Yoshinori Miyaki, Toshiaki Ohta, Seiji Nakamura, Mayu Ikeda, Kazuyoshi Curr Pharm Des Article Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design. Bentham Science Publishers 2016-07 2016-07 /pmc/articles/PMC5080912/ /pubmed/27075578 http://dx.doi.org/10.2174/1381612822666160414142547 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Fukunishi, Yoshifumi
Mashimo, Tadaaki
Misoo, Kiyotaka
Wakabayashi, Yoshinori
Miyaki, Toshiaki
Ohta, Seiji
Nakamura, Mayu
Ikeda, Kazuyoshi
Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title_full Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title_fullStr Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title_full_unstemmed Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title_short Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
title_sort miscellaneous topics in computer-aided drug design: synthetic accessibility and gpu computing, and other topics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080912/
https://www.ncbi.nlm.nih.gov/pubmed/27075578
http://dx.doi.org/10.2174/1381612822666160414142547
work_keys_str_mv AT fukunishiyoshifumi miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT mashimotadaaki miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT misookiyotaka miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT wakabayashiyoshinori miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT miyakitoshiaki miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT ohtaseiji miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT nakamuramayu miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics
AT ikedakazuyoshi miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics